neews release VANCOUVER, British Columbia, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that the Company will be displaying a booth at the O’Cannabiz Conference and Expo taking place at Parq Casino in Vancouver, BC on December 10-11th, 2018 (“O’Cannabiz”).
O’Cannabiz will address key cannabis investment themes, emerging opportunities in the developing Canadian market, as well as significant trends and developments in the cannabis industry, from consumers to businesses. The conference will display over 100 global and local cannabis professionals, offering attendees and investors up to date information on what’s next for Canada’s growing cannabis industry.
Abattis’ Corporate Communications representative Mr. Jonathan Danieli will be available to meet for one-on-one discussions with institutional investors throughout the day along with selected members of Abattis’ senior management including the Company’s recently appointed Chief Operations Officer Mr. Patrick Mitchell, who will be available on December 11th, 2018.
“Abattis is excited to engage in one-on-one discussions with the public investment community as the feedback and commentary that will be received is very important, both from an investor’s perspective as well as from a company perspective. Abattis has big plans for 2019 as the Canadian adult recreational market continues to mature and grow, and our many stakeholders continue to watch the Company’s growth very closely,” stated Mr. Mitchell. “With incredibly volatile market conditions, it’s important for our management and staff to seize opportunities such as O’Cannabiz to create and foster personal connections and to have meaningful conversations to ensure our stakeholders are kept up to date with the progress of the Company.”
During the conference, investors and other interested parties will have a chance to get an inside look at the developments and progress of the Company’s wholly-owned subsidiary, Gabriola Green Farms Inc.’s greenhouse facilities located on Gabriola Island, BC, as well as to have an opportunity to view and purchase the Company’s other various products including its full vaporizer line, its newly launched cannabinoid-infused nutraceutical, Comfort, and its newly acquired fertilizer line of products through NutriVida Corp.
About Abattis Bioceuticals Corp.
Abattis is a life sciences and biotechnology company which aggregates, integrates, and invests in cannabis technologies and biotechnology services for the legal cannabis industry developing in Canada. The Company has successfully developed and licensed natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. The Company is also seeking to acquire exclusive intellectual property rights to agricultural technologies to be employed in extraction and processing of botanical ingredients and compounds. The Company follows strict standard operating protocols and adheres to applicable laws of Canada and foreign jurisdictions.
Read more at https://www.stockhouse.com/news/press-releases/2018/12/10/abattis-to-display-products-and-services-at-ocannabiz-conference-on-december#K8gLJ1UfYpYjlG9w.99